Comments
Court approves Amgen's $762 million payment in drug case
20.12.2012. | NEW YORK (Reuters) - A federal judge on Wednesday approved a $762 million payment from Amgen Inc, the final step to resolve nearly a dozen criminal and civil cases stemming from the sale of its once-blockbuster anemia drug Aranesp and several others....
